As of Aug 17
| -0.014 / -5.00%|
The 2 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 3.25, with a high estimate of 4.50 and a low estimate of 2.00. The median estimate represents a +1,121.80% increase from the last price of 0.27.
The current consensus among 2 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.